PLP1 and myeloid sarcoma: Western blots against PLP1 in the P15 mPFC showed an increase in PLP1 levels after MS (0.45 + /–0.07; n = 5) compared to SFR (0.27+/–0.06; n = 5; p < 0.01) (Supplementary Fig. 1c, d).